{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:10:22Z","timestamp":1790719822109,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900166"],"award-info":[{"award-number":["81900166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900163"],"award-info":[{"award-number":["81900163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970118"],"award-info":[{"award-number":["81970118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhenjiang Clinical Research Center of Hematology","award":["SS2018009"],"award-info":[{"award-number":["SS2018009"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2020055"],"award-info":[{"award-number":["SH2020055"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2021052"],"award-info":[{"award-number":["SH2021052"]}]},{"name":"Medical Field of Zhenjiang \u201cJin Shan Ying Cai\u201d Project"},{"name":"Medical Education Collaborative Innovation Fund of Jiangsu University","award":["JDY2022011"],"award-info":[{"award-number":["JDY2022011"]}]},{"name":"Scientific Research Foundation of Affiliated People\u2019s Hospital of Jiangsu University for PhD","award":["KFB202002"],"award-info":[{"award-number":["KFB202002"]}]},{"name":"Scientific Research Foundation of Affiliated People\u2019s Hospital of Jiangsu University for PhD","award":["KFB202202"],"award-info":[{"award-number":["KFB202202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Previously, we reported the expression of<jats:italic>DLX4<\/jats:italic>isoforms (<jats:italic>BP1<\/jats:italic>and<jats:italic>DLX7<\/jats:italic>) in myeloid leukemia, but the functional role of<jats:italic>DLX4<\/jats:italic>isoforms remains poorly understood. In the work described herein, we further determined the underlying role of<jats:italic>DLX4<\/jats:italic>isoforms in chronic myeloid leukemia (CML) leukemogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The expression and methylation of<jats:italic>DLX4<\/jats:italic>isoforms were detected by real-time quantitative PCR (RT-qPCR) and real-time quantitative methylation-specific PCR (RT-qMSP) in patients with CML. The functional role of<jats:italic>DLX4<\/jats:italic>isoforms was determined in\u00a0vitro and in\u00a0vivo. The molecular mechanism of<jats:italic>DLX4<\/jats:italic>isoforms in leukemogenesis was identified based on chromatin immunoprecipitation with high-throughput sequencing (ChIP-Seq)\/assay for\u00a0transposase-accessible chromatin with high-throughput sequencing (ATAC-Seq) and RNA sequencing (RNA-Seq).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>BP1<\/jats:italic>expression was increased in patients with CML with unmethylated promoter, but<jats:italic>DLX7<\/jats:italic>expression was decreased with hypermethylated promoter. Functionally, overexpression of<jats:italic>BP1<\/jats:italic>increased the proliferation rate of K562 cells with S\/G2 promotion, whereas<jats:italic>DLX7<\/jats:italic>overexpression reduced the proliferation rate of K562 cells with G1 arrest. Moreover, K562 cells with<jats:italic>BP1<\/jats:italic>overexpression increased the tumorigenicity in NCG mice, whereas K562 cells with<jats:italic>DLX7<\/jats:italic>overexpression decreased the tumorigenicity. Mechanistically, a total of 91 genes including 79 messenger RNAs (mRNAs) and 12 long noncoding RNAs (lncRNAs) were discovered by ChIP-Seq and RNA-Seq as direct downstream targets of<jats:italic>BP1<\/jats:italic>. Among the downstream genes, knockdown of<jats:italic>RREB1<\/jats:italic>and<jats:italic>SGMS1-AS1<\/jats:italic>partially revived the proliferation caused by<jats:italic>BP1<\/jats:italic>overexpression in K562 cells. Similarly, using ATAC-Seq and RNA-Seq, a total of 282 genes including 151 mRNA and 131 lncRNAs were identified as direct downstream targets of<jats:italic>DLX7<\/jats:italic>. Knockdown of downstream genes<jats:italic>PTPRB<\/jats:italic>and<jats:italic>NEAT1<\/jats:italic>partially revived the proliferation caused by<jats:italic>DLX7<\/jats:italic>overexpression in K562 cells. Finally, we also identified and validated a<jats:italic>SGMS1-AS1<\/jats:italic>\/<jats:italic>miR-181d-5p<\/jats:italic>\/<jats:italic>SRPK2<\/jats:italic>competing endogenous RNA (ceRNA) network caused by<jats:italic>BP1<\/jats:italic>overexpression in K562 cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The current findings reveal that DNA methylation-mediated differential expression of<jats:italic>DLX4<\/jats:italic>isoforms<jats:italic>BP1<\/jats:italic>and<jats:italic>DLX7<\/jats:italic>plays opposite functions in leukemogenesis.<jats:italic>BP1<\/jats:italic>plays an oncogenic role in leukemia development, whereas<jats:italic>DLX7<\/jats:italic>acts as a tumor suppressor gene. These results suggest<jats:italic>DLX4<\/jats:italic>as a therapeutic target for antileukemia therapy.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s11658-022-00358-0","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T13:05:43Z","timestamp":1658840743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis"],"prefix":"10.1186","volume":"27","author":[{"given":"Jing-dong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-yan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-mei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"issue":"12","key":"358_CR1","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2021.10.006","volume":"42","author":"J Cosgrove","year":"2021","unstructured":"Cosgrove J, Hustin LSP, de Boer RJ, Peri\u00e9 L. Hematopoiesis in numbers. Trends Immunol. 2021;42(12):1100\u201312.","journal-title":"Trends Immunol"},{"key":"358_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375: n2026.","journal-title":"BMJ"},{"issue":"9","key":"358_CR3","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.3390\/ijms22095013","volume":"22","author":"D Venney","year":"2021","unstructured":"Venney D, Mohd-Sarip A, Mills KI. The impact of epigenetic modifications in myeloid malignancies. Int J Mol Sci. 2021;22(9):5013.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"358_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","volume":"35","author":"L Bullinger","year":"2017","unstructured":"Bullinger L, D\u00f6hner K, D\u00f6hner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35(9):934\u201346.","journal-title":"J Clin Oncol"},{"issue":"18","key":"358_CR5","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1182\/blood-2013-01-451781","volume":"121","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab O, Levine RL. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood. 2013;121(18):3563\u201372.","journal-title":"Blood"},{"issue":"18","key":"358_CR6","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.3390\/ijms20184576","volume":"20","author":"X Yang","year":"2019","unstructured":"Yang X, Wong MPM, Ng RK. Aberrant DNA methylation in acute myeloid leukemia and its clinical implications. Int J Mol Sci. 2019;20(18):4576.","journal-title":"Int J Mol Sci"},{"key":"358_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17746","author":"S Kayser","year":"2022","unstructured":"Kayser S, Levis MJ. Updates on targeted therapies for acute myeloid leukaemia. Br J Haematol. 2022. https:\/\/doi.org\/10.1111\/bjh.17746.","journal-title":"Br J Haematol"},{"issue":"6","key":"358_CR8","first-page":"619","volume":"44","author":"GR Merlo","year":"2000","unstructured":"Merlo GR, Zerega B, Paleari L, Trombino S, Mantero S, Levi G. Multiple functions of Dlx genes. Int J Dev Biol. 2000;44(6):619\u201326.","journal-title":"Int J Dev Biol"},{"issue":"5","key":"358_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2217\/bmm-2017-0212","volume":"12","author":"Y Lou","year":"2018","unstructured":"Lou Y, Fallah Y, Yamane K, Berg PE. BP1, a potential biomarker for breast cancer prognosis. Biomark Med. 2018;12(5):535\u201345.","journal-title":"Biomark Med"},{"issue":"1","key":"358_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cancergencyto.2008.07.004","volume":"187","author":"LR Cavalli","year":"2008","unstructured":"Cavalli LR, Man YG, Schwartz AM, Rone JD, Zhang Y, Urban CA, Lima RS, Haddad BR, Berg PE. Amplification of the BP1 homeobox gene in breast cancer. Cancer Genet Cytogenet. 2008;187(1):19\u201324.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"358_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/modpathol.2008.168","volume":"22","author":"AM Schwartz","year":"2009","unstructured":"Schwartz AM, Man YG, Rezaei MK, Simmens SJ, Berg PE. BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia. Mod Pathol. 2009;22(1):1\u20136.","journal-title":"Mod Pathol"},{"issue":"4","key":"358_CR12","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/bcr602","volume":"5","author":"SW Fu","year":"2003","unstructured":"Fu SW, Schwartz A, Stevenson H, Pinzone JJ, Davenport GJ, Orenstein JM, Gutierrez P, Simmens SJ, Abraham J, Poola I, Stephan DA, Berg PE. Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Breast Cancer Res. 2003;5(4):R82\u20137.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"358_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10549-004-4492-9","volume":"90","author":"YG Man","year":"2005","unstructured":"Man YG, Fu SW, Schwartz A, Pinzone JJ, Simmens SJ, Berg PE. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat. 2005;90(3):241\u20137.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"358_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3233\/CBM-2009-0563","volume":"5","author":"YG Man","year":"2009","unstructured":"Man YG, Schwartz A, Levine PH, Teal C, Berg PE. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness. Cancer Biomark. 2009;5(1):9\u201317.","journal-title":"Cancer Biomark"},{"issue":"1","key":"358_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2007.00661.x","volume":"99","author":"M Yu","year":"2008","unstructured":"Yu M, Yang Y, Shi Y, Wang D, Wei X, Zhang N, Niu R. Expression level of beta protein 1 mRNA in Chinese breast cancer patients: a potential molecular marker for poor prognosis. Cancer Sci. 2008;99(1):173\u20138.","journal-title":"Cancer Sci"},{"issue":"3","key":"358_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4149\/neo_2014_041","volume":"61","author":"Y Gao","year":"2014","unstructured":"Gao Y, Li Z, Guo X, Liu Y, Zhang K. DLX4 as a prognostic marker for hepatocellular carcinoma. Neoplasma. 2014;61(3):318\u201323.","journal-title":"Neoplasma"},{"issue":"10\u201311","key":"358_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.clinbiochem.2008.03.011","volume":"41","author":"M Yu","year":"2008","unstructured":"Yu M, Wan Y, Zou Q. Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer. Clin Biochem. 2008;41(10\u201311):824\u201330.","journal-title":"Clin Biochem"},{"issue":"11","key":"358_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/sj.leu.2401912","volume":"14","author":"SB Haga","year":"2000","unstructured":"Haga SB, Fu S, Karp JE, Ross DD, Williams DM, Hankins WD, Behm F, Ruscetti FW, Chang M, Smith BD, Becton D, Raimondi SC, Berg PE. BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia. 2000;14(11):1867\u201375.","journal-title":"Leukemia"},{"issue":"2","key":"358_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s13277-011-0282-2","volume":"33","author":"TA Rauch","year":"2012","unstructured":"Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD, Pfeifer GP. DNA methylation biomarkers for lung cancer. Tumour Biol. 2012;33(2):287\u201396.","journal-title":"Tumour Biol"},{"issue":"3","key":"358_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ijc.21054","volume":"116","author":"K Miyamoto","year":"2005","unstructured":"Miyamoto K, Fukutomi T, Akashi-Tanaka S, Hasegawa T, Asahara T, Sugimura T, Ushijima T. Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer. 2005;116(3):407\u201314.","journal-title":"Int J Cancer"},{"issue":"6","key":"358_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4161\/epi.5.6.12179","volume":"5","author":"WG Tong","year":"2010","unstructured":"Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, Estrov Z, Wei Y, Yang H, Keating MJ, Garcia-Manero G. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics. 2010;5(6):499\u2013508.","journal-title":"Epigenetics"},{"issue":"5","key":"358_CR22","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.athoracsur.2014.12.058","volume":"99","author":"H Harada","year":"2015","unstructured":"Harada H, Miyamoto K, Yamashita Y, Taniyama K, Ohdan H, Okada M. Methylated DLX4 predicts response to pathologic stage I non-small cell lung cancer resection. Ann Thorac Surg. 2015;99(5):1746\u201354.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"358_CR23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/dc.23256","volume":"43","author":"J Sakane","year":"2015","unstructured":"Sakane J, Taniyama K, Miyamoto K, Saito A, Kuraoka K, Nishimura T, Sentani K, Oue N, Yasui W. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion. Diagn Cytopathol. 2015;43(6):462\u201370.","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"358_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1515\/cclm-2015-0536","volume":"54","author":"TJ Zhang","year":"2016","unstructured":"Zhang TJ, Zhou JD, Yang DQ, Wang YX, Yao DM, Ma JC, Wen XM, Guo H, Lin J, Qian J. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome. Clin Chem Lab Med. 2016;54(5):865\u201371.","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"358_CR25","doi-asserted-by":"publisher","first-page":"8951","DOI":"10.1007\/s13277-015-4364-4","volume":"37","author":"JD Zhou","year":"2016","unstructured":"Zhou JD, Zhang TJ, Wang YX, Yang DQ, Yang L, Ma JC, Wen XM, Yang J, Lin J, Qian J. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia. Tumour Biol. 2016;37(7):8951\u201360.","journal-title":"Tumour Biol"},{"issue":"4","key":"358_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.bbrc.2015.06.095","volume":"463","author":"JD Zhou","year":"2015","unstructured":"Zhou JD, Wang YX, Zhang TJ, Yang DQ, Yao DM, Guo H, Yang L, Ma JC, Wen XM, Yang J, Lin J, Qian J. Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia. Biochem Biophys Res Commun. 2015;463(4):1250\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"358_CR27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3109\/10428194.2015.1088648","volume":"57","author":"JD Zhou","year":"2016","unstructured":"Zhou JD, Yang J, Guo H, Deng ZQ, Wen XM, Yang L, Yin JY, Xiao GF, Lin J, Qian J. BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia. Leuk Lymphoma. 2016;57(4):828\u201334.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"358_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41419-020-03213-2","volume":"11","author":"JD Zhou","year":"2020","unstructured":"Zhou JD, Zhang TJ, Xu ZJ, Deng ZQ, Gu Y, Ma JC, Wen XM, Leng JY, Lin J, Chen SN, Qian J. Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes. Cell Death Dis. 2020;11(11):997.","journal-title":"Cell Death Dis"},{"issue":"2","key":"358_CR29","volume":"10","author":"TJ Zhang","year":"2020","unstructured":"Zhang TJ, Xu ZJ, Gu Y, Wen XM, Ma JC, Zhang W, Deng ZQ, Leng JY, Qian J, Lin J, Zhou JD. Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms. Clin Transl Med. 2020;10(2): e29.","journal-title":"Clin Transl Med"},{"issue":"1","key":"358_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13148-021-01013-9","volume":"13","author":"TJ Zhang","year":"2021","unstructured":"Zhang TJ, Xu ZJ, Gu Y, Ma JC, Wen XM, Zhang W, Deng ZQ, Qian J, Lin J, Zhou JD. Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia. Clin Epigenetics. 2021;13(1):16.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"358_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s11658-021-00290-9","volume":"26","author":"R Halabian","year":"2021","unstructured":"Halabian R, Ahmadi A, Saeedi P, Azimzadeh Jamalkandi S, Alivand MR. Laboratory methods to decipher epigenetic signatures: a comparative review. Cell Mol Biol Lett. 2021;26(1):46.","journal-title":"Cell Mol Biol Lett"},{"key":"358_CR32","doi-asserted-by":"publisher","first-page":"8806","DOI":"10.1038\/ncomms9806","volume":"6","author":"F Xu","year":"2015","unstructured":"Xu F, Wu LY, Chang CK, He Q, Zhang Z, Liu L, Shi WH, Guo J, Zhu Y, Zhao YS, Gu SC, Fei CM, Wu D, Zhou LY, Su JY, Song LX, Xiao C, Li X. Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes. Nat Commun. 2015;6:8806.","journal-title":"Nat Commun"},{"issue":"8","key":"358_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.7150\/ijbs.4458","volume":"8","author":"L Zhang","year":"2012","unstructured":"Zhang L, Yang M, Gan L, He T, Xiao X, Stewart MD, Liu X, Yang L, Zhang T, Zhao Y, Fu J. DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis. Int J Biol Sci. 2012;8(8):1178\u201387.","journal-title":"Int J Biol Sci"},{"key":"358_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7150\/jca.1.54","volume":"1","author":"Y Fu","year":"2010","unstructured":"Fu Y, Lian Y, Kim KS, Zhang L, Hindle AK, Brody F, Siegel RS, McCaffrey TA, Fu SW. BP1 homeoprotein enhances metastatic potential in ER-negative breast cancer. J Cancer. 2010;1:54\u201362.","journal-title":"J Cancer"},{"issue":"8","key":"358_CR35","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.ajpath.2015.04.004","volume":"185","author":"D Haria","year":"2015","unstructured":"Haria D, Trinh BQ, Ko SY, Barengo N, Liu J, Naora H. The homeoprotein DLX4 stimulates NF-\u03baB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer. Am J Pathol. 2015;185(8):2298\u2013308.","journal-title":"Am J Pathol"},{"key":"358_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.626328","volume":"8","author":"G Sun","year":"2021","unstructured":"Sun G, Ge Y, Zhang Y, Yan L, Wu X, Ouyang W, Wang Z, Ding B, Zhang Y, Long G, Liu M, Shi R, Zhou H, Chen Z, Ye Z. Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial-mesenchymal transition. Front Mol Biosci. 2021;8: 626328.","journal-title":"Front Mol Biosci"},{"key":"358_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.gene.2019.05.028","volume":"707","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wan Y, Jiang Y, Zhang Z, Shu S, Cheng W, Lang J. Overexpression of BP1, an isoform of Homeobox Gene DLX4, promotes cell proliferation, migration and predicts poor prognosis in endometrial cancer. Gene. 2019;707:216\u201323.","journal-title":"Gene"},{"issue":"1\u20132","key":"358_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-1119(01)00716-8","volume":"278","author":"S Fu","year":"2001","unstructured":"Fu S, Stevenson H, Strovel JW, Haga SB, Stamberg J, Do K, Berg PE. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene. 2001;278(1\u20132):131\u20139.","journal-title":"Gene"},{"issue":"5","key":"358_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.7150\/ijbs.6.513","volume":"6","author":"BJ Kluk","year":"2010","unstructured":"Kluk BJ, Fu Y, Formolo TA, Zhang L, Hindle AK, Man YG, Siegel RS, Berg PE, Deng C, McCaffrey TA, Fu SW. BP1, an isoform of DLX4 homeoprotein, negatively regulates BRCA1 in sporadic breast cancer. Int J Biol Sci. 2010;6(5):513\u201324.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"358_CR40","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/bcr1766","volume":"9","author":"HS Stevenson","year":"2007","unstructured":"Stevenson HS, Fu SW, Pinzone JJ, Rheey J, Simmens SJ, Berg PE. BP1 transcriptionally activates bcl-2 and inhibits TNFalpha-induced cell death in MCF7 breast cancer cells. Breast Cancer Res. 2007;9(5):R60.","journal-title":"Breast Cancer Res"},{"issue":"24","key":"358_CR41","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1038\/onc.2011.4","volume":"30","author":"BQ Trinh","year":"2011","unstructured":"Trinh BQ, Barengo N, Naora H. Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-\u03b2 cytostatic program and blocks the antiproliferative effect of TGF-\u03b2. Oncogene. 2011;30(24):2718\u201329.","journal-title":"Oncogene"},{"issue":"7","key":"358_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/gtc.12772","volume":"25","author":"Z Ling","year":"2020","unstructured":"Ling Z, Long X, Li J, Feng M. Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1. Genes Cells. 2020;25(7):466\u201374.","journal-title":"Genes Cells"},{"issue":"7","key":"358_CR43","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.cell.2008.05.024","volume":"133","author":"MF Berger","year":"2008","unstructured":"Berger MF, Badis G, Gehrke AR, Talukder S, Philippakis AA, Pe\u00f1a-Castillo L, Alleyne TM. Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell. 2008;133(7):1266\u201376.","journal-title":"Cell"},{"issue":"1","key":"358_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijbs.5.1","volume":"5","author":"Y Song","year":"2009","unstructured":"Song Y, Dang C, Fu Y, Lian Y, Hottel J, Li X, McCaffrey T, Fu SW. Genome-wide analysis of BP1 transcriptional targets in breast cancer cell line Hs578T. Int J Biol Sci. 2009;5(1):1\u201312.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"358_CR45","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.2353\/ajpath.2007.061025","volume":"170","author":"F Hara","year":"2007","unstructured":"Hara F, Samuel S, Liu J, Rosen D, Langley RR, Naora H. A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2. Am J Pathol. 2007;170(5):1594\u2013606.","journal-title":"Am J Pathol"},{"issue":"3","key":"358_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"issue":"7483","key":"358_CR47","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352.","journal-title":"Nature"},{"issue":"10","key":"358_CR48","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/2159-8290.CD-13-0202","volume":"3","author":"FA Karreth","year":"2013","unstructured":"Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3(10):1113\u201321.","journal-title":"Cancer Discov"},{"issue":"25","key":"358_CR49","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/onc.2014.274","volume":"34","author":"R Su","year":"2015","unstructured":"Su R, Lin HS, Zhang XH, Yin XL, Ning HM, Liu B, Zhai PF, Gong JN, Shen C, Song L, Chen J, Wang F, Zhao HL, Ma YN, Yu J, Zhang JW. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene. 2015;34(25):3226\u201339.","journal-title":"Oncogene"},{"key":"358_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.654411","volume":"11","author":"M Zhou","year":"2021","unstructured":"Zhou M, Yin X, Zheng L, Fu Y, Wang Y, Cui Z, Gao Z, Wang X, Huang T, Jia J, Chen C. miR-181d\/RBP2\/NF-\u03baB p65 feedback regulation promotes chronic myeloid leukemia blast crisis. Front Oncol. 2021;11: 654411.","journal-title":"Front Oncol"},{"issue":"12","key":"358_CR51","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-08-0021","volume":"68","author":"SW Jang","year":"2008","unstructured":"Jang SW, Yang SJ, Ehl\u00e9n A, Dong S, Khoury H, Chen J, Persson JL, Ye K. Serine\/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1. Cancer Res. 2008;68(12):4559\u201370.","journal-title":"Cancer Res"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-022-00358-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T23:59:01Z","timestamp":1700870341000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-022-00358-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/s11658-022-00358-0","relation":{},"ISSN":["1425-8153","1689-1392"],"issn-type":[{"value":"1425-8153","type":"print"},{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of the Affiliated People\u2019s Hospital of Jiangsu University (no. K-20190016, date: 25\/02\/2019) in accordance with the Declaration of Helsinki. Written informed consent was obtained from all enrolled individuals prior to their participation. All mouse experiments were approved by the Committee on the Ethics of Animal Experiments of Jiangsu University (no. UJS-IACUC-AP-20190305073, date: 5\/3\/2019) in compliance with the Basel Declaration additionally.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}